SouthState Corp’s Sage Therapeutics SAGE Stock Holding History

SouthState Corp’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9	Closed	-$82	–	1566
2025 Q2	$82	Hold	9	–	–	﹤0.01%	1570
2025 Q1	$72	Hold	9	–	–	﹤0.01%	1686
2024 Q4	$49	Hold	9	–	–	﹤0.01%	668
2024 Q3	$65	Hold	9	–	–	﹤0.01%	604
2024 Q2	$98	Hold	9	–	–	﹤0.01%	632
2024 Q1	$169	Hold	9	–	–	﹤0.01%	667
2023 Q4	$195	Hold	9	–	–	﹤0.01%	586
2023 Q3	$185	Hold	9	–	–	﹤0.01%	620
2023 Q2	$423	Hold	9	–	–	﹤0.01%	582
2023 Q1	$378	Hold	9	–	–	﹤0.01%	635
2022 Q4	$343	Hold	9	–	–	﹤0.01%	685
2022 Q3	$0	Hold	9	–	–	﹤0.01%	725
2022 Q2	$0	Hold	9	–	–	﹤0.01%	743
2022 Q1	$0	Hold	9	–	–	﹤0.01%	759
2021 Q4	$0	Hold	9	–	–	﹤0.01%	732
2021 Q3	$0	Buy	+9	New	+$413	﹤0.01%	570

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

SouthState Corp's SAGE Position: Q3 2025 in Review

SouthState Corp sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 9 shares — an estimated $82 sold.

SouthState Corp first reported a position in SAGE in Q3 2021 and held it in 16 quarters. The position peaked at $423 in Q2 2023. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

SouthState Corp reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
SouthState Corp sold 9 Sage Therapeutics shares in Q3 2025, an estimated $82.
SouthState Corp first reported a position in Sage Therapeutics in Q3 2021 and held it in 16 quarters.
SouthState Corp's Sage Therapeutics position peaked at $423 in Q2 2023.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on SouthState Corp's 13F filing for Q3 2025, filed 5 Nov 2025.